Simpson–Golabi–Behmel syndrome human adipocytes reveal a changing phenotype throughout differentiation
- 49 Downloads
The Simpson–Golabi–Behmel syndrome (SGBS) cell strain is widely considered to be a representative in vitro model of human subcutaneous white pre-adipocytes. These cells achieve a transient expression of classical brown markers, such as uncoupling protein 1, peaking at day 14 of differentiation and decreasing thereafter. Adipocyte browning process involves dynamic changes in lipid droplet (LD) dimension, in mitochondria morphology, and in the expression of brown-specific marker genes. This study analyzes SGBS transient phenotypic transformation by quantifying the heterogeneity of LDs, mitochondrial dynamics, and a panel of genes involved in adipocyte differentiation and browning. LDs at 21 days of differentiation were larger than in the previous stages, without any change in the number per cell. The expression of genes such as peroxisome peroxisome proliferator-activated receptor γ, leptin, and lipase E significantly raised from 0 to 21 days. Adiponectin was significantly upregulated at 14 days of differentiation. Brown-specific marker PR domain containing 16 was highly expressed at D0. The variability of mitochondrial shape and interconnectivity reflects differences in the relative rates of fusion and fission, resulting in a significant shift from a networked shape at D7 to a fragmented and swollen one at D14 and D21. The transient phenotype experienced by this cellular model should be considered whether used in studies involving the stimulation of adipocyte browning and could be an interesting human model to further elucidate the browning process in the absence of any stimulation.
KeywordsSGBS adipocytes UCP1 expression Lipid droplets Mito-Morphology
We thank Dr. Martin Wabitsch (Division of Pediatric Endocrinology, Department of Pediatrics and Adolescent Medicine, University of Ulm, Ulm, Germany) for providing the SGBS cells.
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- Aprile M, Ambrosio MR, D’Esposito V, Beguinot F, Formisano P, Costa V, Ciccodicola A (2014) PPARG in human adipogenesis: differential contribution of canonical transcripts and dominant negative isoforms. PPAR Res 2014:537865. https://doi.org/10.1155/2014/537865
- Bäcker V (2012) ImageJ macro tool sets for biological image analysis. In: ImageJ User and Developer ConferenceGoogle Scholar
- Guennoun A, Kazantzis M, Thomas R, Wabitsch M, Tews D, Seetharama Sastry K, Abdelkarim M, Zilberfarb V, Strosberg AD, Chouchane L (2015) Comprehensive molecular characterization of human adipocytes reveals a transient brown phenotype. J Transl Med 13:135. https://doi.org/10.1186/s12967-015-0480-6 CrossRefPubMedPubMedCentralGoogle Scholar
- Leonard AP, Cameron RB, Speiser JL, Wolf BJ, Peterson YK, Schnellmann RG, Beeson CC, Rohrer B (2015) Quantitative analysis of mitochondrial morphology and membrane potential in living cells using high-content imaging, machine learning, and morphological binning. Biochim Biophys Acta 1853(2):348–360. https://doi.org/10.1016/j.bbamcr.2014.11.002 CrossRefPubMedGoogle Scholar
- Park G, Horie T, Kanayama T, Fukasawa K, Iezaki T, Onishi Y, Ozaki K, Nakamura Y, Yoneda Y, Takarada T, Hinoi E (2017) The transcriptional modulator Irfd1 controls PGC-1α expression under short-term adrenergic stimulation in brown adipocytes. FEBS J 284(5):784–795. https://doi.org/10.1111/febs.14019 CrossRefPubMedGoogle Scholar
- Pradhan RN, Zachara M, Deplancke B (2017) A systemic perspective on brown adipogenesis and metabolic activation. Obes Rev 18(Suppl 1):65–81. https://doi.org/10.1111/obr.12512
- Tapia P, Fernández-Galilea M, Robledo F, Mardones P, Galgani JE, Cortés VA (2017) Biology and pathological implications of brown adipose tissue: promises and caveats for the control of obesity and its associated complications. Biol Rev Camb Philos Soc. https://doi.org/10.1111/brv.12389 PubMedGoogle Scholar